Subscribe for perks & to support LI

Your Interests & Preferences: Personalise your reading

Which best describes your role and/or interests?

I work in a law firm
I work for a company / in-house
I'm a litigator at the bar
I'm a law student
Aspiring law student
Save setting
Or click here to show more preferences...

I am interested in the following types of stories (uncheck to hide from frontpage)

Firms / In-House
Legal Education

Always show me: (overrides the above)

Exclusives & Editor's Picks

Website Look & Feel

Light Text on Dark Background

Save preferences

Note: Your preferences will be saved in your browser. You can always change your settings by clicking the Your Preferences button at the top of every page.

Reset preferences to defaults?

Over half-dozen law firms bag mandates in Mylan Inc buying Famy contraceptives for $800m

Crawford Bayley, AZB & Partners and Covington Burling advised Mumbai-based Famy Care on the $800m (Rs 4,944 crore) acquisition of its female contraceptives business by the world’s second largest drug maker Mylan.

Mylan was advised by Luthra & Luthra and Cravath Swaine & Moore. Platinum Partners and Debevoise & Plimpton advised Famy’s existing investor AIF Capital.

Famy drafted in both AZB and Crawford Bayley on Indian laws.

Crawford Bayley was led by senior partner Sanjay Asher, principal associate Bhumika Batra and associates Sanskriti Relekar, Anuja Takle, Aparajita Chakraborty and Avanti Kale.

The AZB team was led by partner Shuva Mandal and associate Sayak Maity.

Covington partners Jack Bodner and Ralph C Voltmer also acted for Famy on US laws.

Luthra senior partner Mohit Saraf and partner Sudipta Routh acted for Mylan.

Mylan also instructed Cravath partners Mark I Greene and Minh Van Ngo, with associates Kyle C Harmon and Zara Bari leading on the acquisition.

Platinum partner Ankit Majmudar and Debevoise London partner Geoffrey P Burgess and associate Shashwat Patel and Hong Kong associate Parveet Singh Gandoak acted for AIF which, along with the promoters of Famy Care, will get $50m from Mylan according to the Economic Times.

This is Mylan’s second major deal with an Indian drug maker since its $1.6bn acquisition of part of Strides in 2013, reported Mint, on which Platinum had acted for Mylan alongside DSK Legal and Skadden Arps for the target.

Click to show 8 comments
at your own risk
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.
refresh Filter out low-rated comments. Show all comments. Sort chronologically
Like +0 Object -0 Typo? 03 Feb 15, 14:37
Ankit Majmudar not Majumdar.
Reply Report to LI
Like +0 Object -0 kianganz 03 Feb 15, 14:39
Thanks & sorry for the typo!
Reply Report to LI
Like +3 Object -0 Guest 03 Feb 15, 19:10
Reply Report to LI
Like +2 Object -0 Singking 04 Feb 15, 15:46
Great deal to add to luthra's trophy table....we all know that in acquisition deals like this...its the acquirer counsel that takes lead on the transaction.....this follows the largest M&A of this year- the prestigious Ranbaxy-Sun Pharma transaction...where they are leading the deal on account of being transferor counsels....they sure are getting back in their groove! Come on luthra trollers....where are you thou?
Reply Report to LI
Like +0 Object -1 Troll Master @ Ashoka 9th Floo 04 Feb 15, 16:33
Here i am. So which floor are you on? Im guessing somewhere on the 9th floor within kissing distance of the short stick?
Reply Report to LI
Like +0 Object -0 Singking 04 Feb 15, 17:08
And you....I am sure are bearing the brunt of all the long sticks these days...that explains your frustration and would have been funny...but laudable...had you tried to use your intelligence to counter!
Reply Report to LI
Like +1 Object -0 Shooter 04 Feb 15, 22:29
i bet you know what the short stick had for breakfast coz you are so far up his .....
Reply Report to LI
Like +0 Object -0 Well wisher 06 Feb 15, 16:03
Great going Luthra! On track to beat all expectations.
Reply Report to LI

Latest comments